Climb Bio, Inc. (CLYM)
NGM · Common · CUSIP 28658R106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CLYM and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
28658R106
IPO
8/10/2021 · $12.50/share
Previous Symbol
ELYM (changed 9/20/2024)
Previous Name
Eliem Therapeutics, Inc
Business: Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases.

Company Contact

CEO
Aoife Brennan
CFO
Erin M. Lavelle
Headquarters
20 William Street, Suite 145, Wellesley Hills, MA 02481
Phone
866-857-2596 · Toll-Free 866-857-2596
Investor Relations
Carlo Tanzi Kendall IR · ctanzi@kendallir.com
SEC EDGAR Filings
View filings »